← Leaderboards
Jingzhong Ding
Wake Forest University Health Sciences
$9,573,787
Attributed
$19,236,353
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,236,353 · 7
By mechanism
R01$11,933,933 · 5
RF1$4,132,612 · 1
U01$3,169,808 · 1
Top collaborators
- Yongmei Liu18 shared
- Osvaldo Delbono8 shared
- Anthony J Molina8 shared
- Stephen B Kritchevsky3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Barry Ira Freedman$20,046,491
- Rasika Ann Mathias$10,122,218
- Christina E Hugenschmidt$4,271,099
- T Michael O'Shea$19,989,878
- Carl D Langefeld$5,554,144
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantMonocyteCellsSamplingGenesTranscriptomicsFollow-UpPhenotypeEpigenetic ProcessInflammationSiteExperimental StudyRisk FactorsMediatingCostMulti-Ethnic Study Of AtherosclerosisAnimalsGeneticSignal TransductionObesityInflammatoryMethylationReportingAging
Grant awards (31)
T helper cells in development of chronic inflammation and multimorbidity$601,436
R01 · FY2025 · AG · contact PI
T helper cells in development of chronic inflammation and multimorbidity$626,628
R01 · FY2024 · AG · contact PI
T helper cells in development of chronic inflammation and multimorbidity$661,842
R01 · FY2023 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$562,689
U01 · FY2022 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$40,400
U01 · FY2022 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$547,101
U01 · FY2021 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$34,863
U01 · FY2021 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$631,270
U01 · FY2020 · AG · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$457,397
R01 · FY2020 · DK · contact PI
Epigenetics of Weight Loss and Glycemic Improvement$654,447
R01 · FY2019 · DK · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$622,593
U01 · FY2019 · AG · contact PI
Cell-specific genomic features of Alzheimer's disease progression$387,500
RF1 · FY2019 · AG · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$110,972
U01 · FY2019 · AG · contact PI
Obesity-related epigenetic changes and type-2 diabetes$646,075
R01 · FY2018 · DK
Epigenetics of Weight Loss and Glycemic Improvement$644,740
R01 · FY2018 · DK · contact PI
Aging Biomarkers: Integrating Omic Profiles with Mechanistic Measures$619,920
U01 · FY2018 · AG · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$336,656
R01 · FY2018 · HL
Cell-specific genomic features of Alzheimer's disease progression$3,745,112
RF1 · FY2017 · AG · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$746,222
R01 · FY2017 · HL
Epigenetics of Weight Loss and Glycemic Improvement$663,562
R01 · FY2017 · DK · contact PI
Obesity-related epigenetic changes and type-2 diabetes$651,436
R01 · FY2017 · DK
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$764,754
R01 · FY2016 · HL
Obesity-related epigenetic changes and type-2 diabetes$742,998
R01 · FY2016 · DK
Epigenetics of Weight Loss and Glycemic Improvement$661,862
R01 · FY2016 · DK · contact PI
Epigenetic roles in regulation of cholesterol metabolism and CVD risk$785,637
R01 · FY2015 · HL
Obesity-related epigenetic changes and type-2 diabetes$690,448
R01 · FY2015 · DK
Pericardial fat and subclinical and clinical measures of coronary heart disease$350,084
R01 · FY2009 · HL · contact PI
Pericardial fat and subclinical and clinical measures of coronary heart disease$188,795
R01 · FY2009 · HL · contact PI
Pericardial fat and subclinical and clinical measures of coronary heart disease$343,033
R01 · FY2008 · HL · contact PI
Pericardial fat and subclinical and clinical measures of coronary heart disease$349,795
R01 · FY2007 · HL · contact PI
Pericardial fat and subclinical and clinical measures of coronary heart disease$366,086
R01 · FY2006 · HL · contact PI